Copyright Reports & Markets. All rights reserved.

Global Demineralized Allograft Bone Substitute Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Demineralized Allograft Bone Substitute Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Gel
    • 1.3.3 Putty
    • 1.3.4 Putty with Chips
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Demineralized Allograft Bone Substitute Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Dental Surgery
    • 1.4.3 Spine Surgery
    • 1.4.4 Trauma Surgery
  • 1.5 Global Demineralized Allograft Bone Substitute Market Size & Forecast
    • 1.5.1 Global Demineralized Allograft Bone Substitute Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Demineralized Allograft Bone Substitute Sales Quantity (2021-2032)
    • 1.5.3 Global Demineralized Allograft Bone Substitute Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Medtronic
    • 2.1.1 Medtronic Details
    • 2.1.2 Medtronic Major Business
    • 2.1.3 Medtronic Demineralized Allograft Bone Substitute Product and Services
    • 2.1.4 Medtronic Demineralized Allograft Bone Substitute Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Medtronic Recent Developments/Updates
  • 2.2 J &J (DePuy Synthes)
    • 2.2.1 J &J (DePuy Synthes) Details
    • 2.2.2 J &J (DePuy Synthes) Major Business
    • 2.2.3 J &J (DePuy Synthes) Demineralized Allograft Bone Substitute Product and Services
    • 2.2.4 J &J (DePuy Synthes) Demineralized Allograft Bone Substitute Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 J &J (DePuy Synthes) Recent Developments/Updates
  • 2.3 SeaSpine
    • 2.3.1 SeaSpine Details
    • 2.3.2 SeaSpine Major Business
    • 2.3.3 SeaSpine Demineralized Allograft Bone Substitute Product and Services
    • 2.3.4 SeaSpine Demineralized Allograft Bone Substitute Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 SeaSpine Recent Developments/Updates
  • 2.4 Xtant Medical
    • 2.4.1 Xtant Medical Details
    • 2.4.2 Xtant Medical Major Business
    • 2.4.3 Xtant Medical Demineralized Allograft Bone Substitute Product and Services
    • 2.4.4 Xtant Medical Demineralized Allograft Bone Substitute Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Xtant Medical Recent Developments/Updates
  • 2.5 Zimmer Biomet
    • 2.5.1 Zimmer Biomet Details
    • 2.5.2 Zimmer Biomet Major Business
    • 2.5.3 Zimmer Biomet Demineralized Allograft Bone Substitute Product and Services
    • 2.5.4 Zimmer Biomet Demineralized Allograft Bone Substitute Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Zimmer Biomet Recent Developments/Updates
  • 2.6 Stryker
    • 2.6.1 Stryker Details
    • 2.6.2 Stryker Major Business
    • 2.6.3 Stryker Demineralized Allograft Bone Substitute Product and Services
    • 2.6.4 Stryker Demineralized Allograft Bone Substitute Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Stryker Recent Developments/Updates
  • 2.7 Straumann
    • 2.7.1 Straumann Details
    • 2.7.2 Straumann Major Business
    • 2.7.3 Straumann Demineralized Allograft Bone Substitute Product and Services
    • 2.7.4 Straumann Demineralized Allograft Bone Substitute Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Straumann Recent Developments/Updates
  • 2.8 Wright Medical Group
    • 2.8.1 Wright Medical Group Details
    • 2.8.2 Wright Medical Group Major Business
    • 2.8.3 Wright Medical Group Demineralized Allograft Bone Substitute Product and Services
    • 2.8.4 Wright Medical Group Demineralized Allograft Bone Substitute Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Wright Medical Group Recent Developments/Updates
  • 2.9 Hans Biomed
    • 2.9.1 Hans Biomed Details
    • 2.9.2 Hans Biomed Major Business
    • 2.9.3 Hans Biomed Demineralized Allograft Bone Substitute Product and Services
    • 2.9.4 Hans Biomed Demineralized Allograft Bone Substitute Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Hans Biomed Recent Developments/Updates
  • 2.10 Arthrex
    • 2.10.1 Arthrex Details
    • 2.10.2 Arthrex Major Business
    • 2.10.3 Arthrex Demineralized Allograft Bone Substitute Product and Services
    • 2.10.4 Arthrex Demineralized Allograft Bone Substitute Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Arthrex Recent Developments/Updates

3 Competitive Environment: Demineralized Allograft Bone Substitute by Manufacturer

  • 3.1 Global Demineralized Allograft Bone Substitute Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Demineralized Allograft Bone Substitute Revenue by Manufacturer (2021-2026)
  • 3.3 Global Demineralized Allograft Bone Substitute Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Demineralized Allograft Bone Substitute by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Demineralized Allograft Bone Substitute Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Demineralized Allograft Bone Substitute Manufacturer Market Share in 2025
  • 3.5 Demineralized Allograft Bone Substitute Market: Overall Company Footprint Analysis
    • 3.5.1 Demineralized Allograft Bone Substitute Market: Region Footprint
    • 3.5.2 Demineralized Allograft Bone Substitute Market: Company Product Type Footprint
    • 3.5.3 Demineralized Allograft Bone Substitute Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Demineralized Allograft Bone Substitute Market Size by Region
    • 4.1.1 Global Demineralized Allograft Bone Substitute Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Demineralized Allograft Bone Substitute Consumption Value by Region (2021-2032)
    • 4.1.3 Global Demineralized Allograft Bone Substitute Average Price by Region (2021-2032)
  • 4.2 North America Demineralized Allograft Bone Substitute Consumption Value (2021-2032)
  • 4.3 Europe Demineralized Allograft Bone Substitute Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Demineralized Allograft Bone Substitute Consumption Value (2021-2032)
  • 4.5 South America Demineralized Allograft Bone Substitute Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Demineralized Allograft Bone Substitute Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Demineralized Allograft Bone Substitute Sales Quantity by Type (2021-2032)
  • 5.2 Global Demineralized Allograft Bone Substitute Consumption Value by Type (2021-2032)
  • 5.3 Global Demineralized Allograft Bone Substitute Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Demineralized Allograft Bone Substitute Sales Quantity by Application (2021-2032)
  • 6.2 Global Demineralized Allograft Bone Substitute Consumption Value by Application (2021-2032)
  • 6.3 Global Demineralized Allograft Bone Substitute Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Demineralized Allograft Bone Substitute Sales Quantity by Type (2021-2032)
  • 7.2 North America Demineralized Allograft Bone Substitute Sales Quantity by Application (2021-2032)
  • 7.3 North America Demineralized Allograft Bone Substitute Market Size by Country
    • 7.3.1 North America Demineralized Allograft Bone Substitute Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Demineralized Allograft Bone Substitute Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Demineralized Allograft Bone Substitute Sales Quantity by Type (2021-2032)
  • 8.2 Europe Demineralized Allograft Bone Substitute Sales Quantity by Application (2021-2032)
  • 8.3 Europe Demineralized Allograft Bone Substitute Market Size by Country
    • 8.3.1 Europe Demineralized Allograft Bone Substitute Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Demineralized Allograft Bone Substitute Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Demineralized Allograft Bone Substitute Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Demineralized Allograft Bone Substitute Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Demineralized Allograft Bone Substitute Market Size by Region
    • 9.3.1 Asia-Pacific Demineralized Allograft Bone Substitute Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Demineralized Allograft Bone Substitute Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Demineralized Allograft Bone Substitute Sales Quantity by Type (2021-2032)
  • 10.2 South America Demineralized Allograft Bone Substitute Sales Quantity by Application (2021-2032)
  • 10.3 South America Demineralized Allograft Bone Substitute Market Size by Country
    • 10.3.1 South America Demineralized Allograft Bone Substitute Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Demineralized Allograft Bone Substitute Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Demineralized Allograft Bone Substitute Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Demineralized Allograft Bone Substitute Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Demineralized Allograft Bone Substitute Market Size by Country
    • 11.3.1 Middle East & Africa Demineralized Allograft Bone Substitute Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Demineralized Allograft Bone Substitute Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Demineralized Allograft Bone Substitute Market Drivers
  • 12.2 Demineralized Allograft Bone Substitute Market Restraints
  • 12.3 Demineralized Allograft Bone Substitute Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Demineralized Allograft Bone Substitute and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Demineralized Allograft Bone Substitute
  • 13.3 Demineralized Allograft Bone Substitute Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Demineralized Allograft Bone Substitute Typical Distributors
  • 14.3 Demineralized Allograft Bone Substitute Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Demineralized Allograft Bone Substitute market size was valued at US$ 662 million in 2025 and is forecast to a readjusted size of US$ 1026 million by 2032 with a CAGR of 6.5% during review period.
    Demineralized bone matrix (DBM) is allograft bone that has had the inorganic mineral removed, leaving behind the organic "collagen" matrix. It was first discovered by Marshall Urist in 1965 that the removal of the bone mineral exposes more biologically active bone morphogenetic proteins. These growth factors modulate the differentiation of progenitor cells into osteoprogenitor cells, which are responsible for bone and cartilage formation. As a result of the demineralization process, DBM is more biologically active than undemineralized bone grafts; conversely the mechanical properties are significantly diminished.
    The demineralized bone matrix market is primarily driven by the increasing demand for bone graft substitutes in orthopedic and dental surgeries. Demineralized bone matrix (DBM) is derived from human or animal bones and contains growth factors and proteins that promote bone regeneration and healing. The rising prevalence of musculoskeletal disorders, trauma, and dental conditions fuels the adoption of DBM as an effective and biocompatible bone graft material. However, the market also faces challenges, including the need for standardized and high-quality DBM products to ensure consistent clinical outcomes. Variability in DBM processing methods and composition may impact its efficacy and safety. Moreover, strict regulatory requirements and ethical concerns related to the sourcing and processing of DBM can pose challenges for manufacturers in the market.
    This report is a detailed and comprehensive analysis for global Demineralized Allograft Bone Substitute market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Demineralized Allograft Bone Substitute market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Demineralized Allograft Bone Substitute market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Demineralized Allograft Bone Substitute market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Demineralized Allograft Bone Substitute market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Demineralized Allograft Bone Substitute
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Demineralized Allograft Bone Substitute market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, J &J (DePuy Synthes), SeaSpine, Xtant Medical, Zimmer Biomet, Stryker, Straumann, Wright Medical Group, Hans Biomed, Arthrex, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Demineralized Allograft Bone Substitute market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Gel
    Putty
    Putty with Chips
    Others
    Market segment by Application
    Dental Surgery
    Spine Surgery
    Trauma Surgery
    Major players covered
    Medtronic
    J &J (DePuy Synthes)
    SeaSpine
    Xtant Medical
    Zimmer Biomet
    Stryker
    Straumann
    Wright Medical Group
    Hans Biomed
    Arthrex
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Demineralized Allograft Bone Substitute product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Demineralized Allograft Bone Substitute, with price, sales quantity, revenue, and global market share of Demineralized Allograft Bone Substitute from 2021 to 2026.
    Chapter 3, the Demineralized Allograft Bone Substitute competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Demineralized Allograft Bone Substitute breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Demineralized Allograft Bone Substitute market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Demineralized Allograft Bone Substitute.
    Chapter 14 and 15, to describe Demineralized Allograft Bone Substitute sales channel, distributors, customers, research findings and conclusion.

    Buy now